Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
1923
Served areaWorldwide
HeadquartersNovo Alle 1, 2880 Bagsværd – Denmark
| Line item in (dkk) | 01.01.2019 | 01.01.2020 | 01.04.2020 | 01.07.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | N/A | N/A | N/A | N/A | 144,922,000,000.00 | 141,387,000,000.00 | 158,095,000,000.00 | N/A | 194,508,000,000.00 | 241,257,000,000.00 | 218,928,000,000.00 | 242,836.00 | 241,257,000,000.00 | 250,025,000,000.00 | 280,753,000,000.00 |
| Noncurrent Assets | N/A | N/A | N/A | N/A | 79,113,000,000.00 | 79,998,000,000.00 | 80,949,000,000.00 | N/A | 108,913,000,000.00 | 133,063,000,000.00 | 115,949,000,000.00 | 123,354.00 | 133,063,000,000.00 | 136,082,000,000.00 | 143,202,000,000.00 |
| Property Plant And Equipment | N/A | N/A | N/A | N/A | 50,269,000,000.00 | 51,429,000,000.00 | 52,076,000,000.00 | N/A | 55,362,000,000.00 | 66,671,000,000.00 | 59,556,000,000.00 | 63,641.00 | 66,671,000,000.00 | 70,014,000,000.00 | 75,024,000,000.00 |
| Intangible Assets Other Than Goodwill | N/A | N/A | N/A | N/A | 20,657,000,000.00 | 20,357,000,000.00 | 20,272,000,000.00 | N/A | 43,171,000,000.00 | 51,416,000,000.00 | 44,590,000,000.00 | 46,924.00 | 51,416,000,000.00 | 50,489,000,000.00 | 50,749,000,000.00 |
| Investments In Associates Accounted For Using Equity Method | N/A | N/A | N/A | N/A | 582,000,000.00 | 563,000,000.00 | 566,000,000.00 | N/A | 525,000,000.00 | 327,000,000.00 | 463,000,000.00 | 458.00 | 327,000,000.00 | 270,000,000.00 | 270,000,000.00 |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | 5,865,000,000.00 | 5,912,000,000.00 | 6,349,000,000.00 | N/A | 8,672,000,000.00 | 13,427,000,000.00 | 10,309,000,000.00 | 11,303.00 | 13,427,000,000.00 | 14,080,000,000.00 | 15,612,000,000.00 |
| Other Noncurrent Financial Assets | N/A | N/A | N/A | N/A | 1,066,000,000.00 | 1,186,000,000.00 | 1,273,000,000.00 | N/A | 916,000,000.00 | 1,016,000,000.00 | 779,000,000.00 | 781.00 | 1,016,000,000.00 | 941,000,000.00 | 1,209,000,000.00 |
| Current Assets | N/A | N/A | N/A | N/A | 65,809,000,000.00 | 61,389,000,000.00 | 77,146,000,000.00 | N/A | 85,595,000,000.00 | 108,194,000,000.00 | 102,979,000,000.00 | 119,482.00 | 108,194,000,000.00 | 113,943,000,000.00 | 137,551,000,000.00 |
| Inventories | N/A | N/A | N/A | N/A | 18,536,000,000.00 | 18,653,000,000.00 | 18,822,000,000.00 | N/A | 19,621,000,000.00 | 24,388,000,000.00 | 21,706,000,000.00 | 23,222.00 | 24,388,000,000.00 | 25,615,000,000.00 | 28,020,000,000.00 |
| Current Trade Receivables | N/A | N/A | N/A | N/A | 27,734,000,000.00 | 28,029,000,000.00 | 26,098,000,000.00 | N/A | 40,643,000,000.00 | 50,560,000,000.00 | 40,826,000,000.00 | 45,563.00 | 50,560,000,000.00 | 50,502,000,000.00 | 61,294,000,000.00 |
| Current Tax Assets Current | N/A | N/A | N/A | N/A | 289,000,000.00 | 1,897,000,000.00 | 344,000,000.00 | N/A | 1,119,000,000.00 | 940,000,000.00 | 1,168,000,000.00 | 2,541.00 | 940,000,000.00 | 1,133,000,000.00 | 2,779,000,000.00 |
| Cash and cash equivalents | 15,629,000,000.00 | 15,411,000,000.00 | 9,713,000,000.00 | 24,851,000,000.00 | 12,226,000,000.00 | 5,679,000,000.00 | 24,227,000,000.00 | 29,490.00 | 10,719,000,000.00 | 13,208,000,000.00 | 22,756,000,000.00 | 27,914.00 | 12,653,000,000.00 | 14,936,000,000.00 | 21,574,000,000.00 |
| Cash | N/A | N/A | N/A | N/A | 12,757,000,000.00 | 5,683,000,000.00 | 24,229,000,000.00 | N/A | 10,720,000,000.00 | 12,653,000,000.00 | 22,758,000,000.00 | 28,465.00 | 12,653,000,000.00 | 14,936,000,000.00 | 21,574,000,000.00 |
| Current Derivative Financial Assets | N/A | N/A | N/A | N/A | 2,332,000,000.00 | 1,153,000,000.00 | 885,000,000.00 | N/A | 1,690,000,000.00 | 2,727,000,000.00 | 3,597,000,000.00 | 5,277.00 | 2,727,000,000.00 | 2,636,000,000.00 | 2,602,000,000.00 |
| Current Investments | N/A | N/A | N/A | N/A | 0.00 | 1,983,000,000.00 | 2,987,000,000.00 | N/A | 6,765,000,000.00 | 10,921,000,000.00 | 8,279,000,000.00 | 9,008.00 | 10,921,000,000.00 | 12,835,000,000.00 | 14,834,000,000.00 |
| Equity And Liabilities | N/A | N/A | N/A | N/A | 144,922,000,000.00 | 141,387,000,000.00 | 158,095,000,000.00 | N/A | 194,508,000,000.00 | 241,257,000,000.00 | 218,928,000,000.00 | 242,836.00 | 241,257,000,000.00 | 250,025,000,000.00 | 280,753,000,000.00 |
| Equity | 51,839,000,000.00 | 57,593,000,000.00 | 54,399,000,000.00 | 60,054,000,000.00 | 63,325,000,000.00 | 58,496,000,000.00 | 65,559,000,000.00 | 66,112.00 | 70,746,000,000.00 | 83,486,000,000.00 | 74,452,000,000.00 | 76,680.00 | 83,486,000,000.00 | 79,874,000,000.00 | 90,473,000,000.00 |
| Issued Capital | N/A | N/A | N/A | N/A | 470,000,000.00 | 470,000,000.00 | 462,000,000.00 | N/A | 462,000,000.00 | 456,000,000.00 | 456,000,000.00 | 456.00 | 456,000,000.00 | 456,000,000.00 | 451,000,000.00 |
| Retained Earnings | N/A | N/A | N/A | N/A | 63,774,000,000.00 | 60,297,000,000.00 | 67,179,000,000.00 | N/A | 72,004,000,000.00 | 80,587,000,000.00 | 73,166,000,000.00 | 73,673.00 | 80,587,000,000.00 | 77,070,000,000.00 | 88,118,000,000.00 |
| Treasury Shares | N/A | N/A | N/A | N/A | 8,000,000.00 | 9,000,000.00 | 3,000,000.00 | N/A | 6,000,000.00 | 6,000,000.00 | 3,000,000.00 | 4.00 | 6,000,000.00 | 6,000,000.00 | 3,000,000.00 |
| Other Reserves | N/A | N/A | N/A | N/A | -911,000,000.00 | -2,262,000,000.00 | -2,079,000,000.00 | N/A | -1,714,000,000.00 | 2,449,000,000.00 | 833,000,000.00 | 2,555.00 | 2,449,000,000.00 | 2,354,000,000.00 | 1,907,000,000.00 |
| Liabilities | N/A | N/A | N/A | N/A | 81,597,000,000.00 | 82,891,000,000.00 | 92,536,000,000.00 | N/A | 123,762,000,000.00 | 157,771,000,000.00 | 144,476,000,000.00 | 166,156.00 | 157,771,000,000.00 | 170,151,000,000.00 | 190,280,000,000.00 |
| Noncurrent Liabilities | N/A | N/A | N/A | N/A | 11,324,000,000.00 | 10,507,000,000.00 | 19,738,000,000.00 | N/A | 24,246,000,000.00 | 36,831,000,000.00 | 34,821,000,000.00 | 35,899.00 | 36,831,000,000.00 | 38,190,000,000.00 | 33,662,000,000.00 |
| Noncurrent Provisions | N/A | N/A | N/A | N/A | 4,526,000,000.00 | 4,508,000,000.00 | 4,241,000,000.00 | N/A | 4,374,000,000.00 | 4,590,000,000.00 | 4,642,000,000.00 | 5,300.00 | 4,590,000,000.00 | 5,044,000,000.00 | 5,728,000,000.00 |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | 2,502,000,000.00 | 1,963,000,000.00 | 1,818,000,000.00 | N/A | 5,271,000,000.00 | 7,061,000,000.00 | 5,217,000,000.00 | 5,640.00 | 7,061,000,000.00 | 7,875,000,000.00 | 7,627,000,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | N/A | N/A | N/A | 1,399,000,000.00 | 1,204,000,000.00 | 1,216,000,000.00 | N/A | 1,280,000,000.00 | 762,000,000.00 | 617,000,000.00 | 583.00 | 762,000,000.00 | 682,000,000.00 | 699,000,000.00 |
| Other Noncurrent Liabilities | N/A | N/A | N/A | N/A | 0.00 | N/A | N/A | N/A | 360,000,000.00 | 100,000,000.00 | 167,000,000.00 | 240.00 | 100,000,000.00 | 322,000,000.00 | 193,000,000.00 |
| Longterm Borrowings | N/A | N/A | N/A | N/A | 2,897,000,000.00 | 2,832,000,000.00 | 12,463,000,000.00 | N/A | 12,961,000,000.00 | 24,318,000,000.00 | 24,178,000,000.00 | 24,136.00 | 24,318,000,000.00 | 24,267,000,000.00 | 19,415,000,000.00 |
| Current Liabilities | N/A | N/A | N/A | N/A | 70,273,000,000.00 | 72,384,000,000.00 | 72,798,000,000.00 | N/A | 99,516,000,000.00 | 120,940,000,000.00 | 109,655,000,000.00 | 130,257.00 | 120,940,000,000.00 | 131,961,000,000.00 | 156,618,000,000.00 |
| Current Provisions | N/A | N/A | N/A | N/A | 34,814,000,000.00 | 38,513,000,000.00 | 46,388,000,000.00 | N/A | 51,520,000,000.00 | 70,287,000,000.00 | 65,788,000,000.00 | 84,745.00 | 70,287,000,000.00 | 87,956,000,000.00 | 98,858,000,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | N/A | N/A | N/A | 5,717,000,000.00 | 6,800,000,000.00 | 7,616,000,000.00 | N/A | 8,870,000,000.00 | 15,587,000,000.00 | 14,654,000,000.00 | 8,310.00 | 15,587,000,000.00 | 10,050,000,000.00 | 17,788,000,000.00 |
| Current Tax Liabilities Current | N/A | N/A | N/A | N/A | 3,913,000,000.00 | 2,905,000,000.00 | 2,902,000,000.00 | N/A | 3,658,000,000.00 | 7,091,000,000.00 | 3,943,000,000.00 | 7,397.00 | 7,091,000,000.00 | 6,062,000,000.00 | 9,617,000,000.00 |
| Current Derivative Financial Liabilities | N/A | N/A | N/A | N/A | 1,365,000,000.00 | 1,235,000,000.00 | 794,000,000.00 | N/A | 2,184,000,000.00 | 2,903,000,000.00 | 4,383,000,000.00 | 6,583.00 | 2,903,000,000.00 | 2,282,000,000.00 | 1,539,000,000.00 |
| Other Current Liabilities | N/A | N/A | N/A | N/A | 17,005,000,000.00 | 16,108,000,000.00 | 13,797,000,000.00 | N/A | 19,600,000,000.00 | 23,606,000,000.00 | 19,631,000,000.00 | 21,389.00 | 23,606,000,000.00 | 24,360,000,000.00 | 22,527,000,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | N/A | N/A | N/A | 7,459,000,000.00 | 6,823,000,000.00 | 1,301,000,000.00 | N/A | 13,684,000,000.00 | 1,466,000,000.00 | 1,256,000,000.00 | 1,833.00 | 1,466,000,000.00 | 1,251,000,000.00 | 6,289,000,000.00 |
| Line item in (dkk) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.04.2020 |
01.01.2020/ 01.07.2020 |
01.01.2020/ 01.01.2021 |
01.04.2020/ 01.07.2020 |
01.01.2021/ 01.04.2021 |
01.01.2021/ 01.07.2021 |
01.01.2021/ 01.10.2021 |
01.01.2021/ 01.01.2022 |
01.04.2021/ 01.07.2021 |
01.07.2021/ 01.10.2021 |
01.01.2022/ 01.04.2022 |
01.01.2022/ 01.07.2022 |
01.01.2022/ 01.10.2022 |
01.01.2022/ 01.01.2023 |
01.04.2022/ 01.07.2022 |
01.07.2022/ 01.10.2022 |
01.01.2023/ 01.04.2023 |
01.01.2023/ 01.07.2023 |
01.04.2023/ 01.07.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 122,021,000,000.00 | 33,875,000,000.00 | 63,881,000,000.00 | 126,946,000,000.00 | 30,006,000,000.00 | 33,804,000,000.00 | 66,845,000,000.00 | 102,467.00 | 140,800,000,000.00 | 33,041,000,000.00 | 35,622.00 | 42,031,000,000.00 | 83,296,000,000.00 | 128,862.00 | 176,954,000,000.00 | 41,265,000,000.00 | 45,566.00 | 53,367,000,000.00 | 107,667,000,000.00 | 54,300,000,000.00 |
| Profit Loss From Operating Activities | 52,483,000,000.00 | 16,302,000,000.00 | 30,140,000,000.00 | 54,126,000,000.00 | 13,838,000,000.00 | 14,982,000,000.00 | 29,761,000,000.00 | 45,010.00 | 58,644,000,000.00 | 14,779,000,000.00 | 15,249.00 | 19,147,000,000.00 | 37,538,000,000.00 | 57,722.00 | 74,809,000,000.00 | 18,391,000,000.00 | 20,184.00 | 25,007,000,000.00 | 48,895,000,000.00 | 23,888,000,000.00 |
| Finance Income | 65,000,000.00 | 17,000,000.00 | 114,000,000.00 | 1,628,000,000.00 | 97,000,000.00 | 1,753,000,000.00 | 1,843,000,000.00 | 2,633.00 | 2,887,000,000.00 | 90,000,000.00 | 790.00 | 210,000,000.00 | 1,866,000,000.00 | 3,439.00 | 239,000,000.00 | 1,656,000,000.00 | 1,573.00 | 852,000,000.00 | 571,000,000.00 | -281,000,000.00 |
| Finance Costs | 3,995,000,000.00 | 1,298,000,000.00 | 1,817,000,000.00 | 2,624,000,000.00 | 519,000,000.00 | 797,000,000.00 | 749,000,000.00 | 1,676.00 | 2,451,000,000.00 | -48,000,000.00 | 927.00 | 1,438,000,000.00 | 4,690,000,000.00 | 8,415.00 | 5,986,000,000.00 | 3,252,000,000.00 | 3,725.00 | 1,122,000,000.00 | 475,000,000.00 | -647,000,000.00 |
| Profit Loss Before Tax | 48,553,000,000.00 | 15,021,000,000.00 | 28,437,000,000.00 | 53,130,000,000.00 | 13,416,000,000.00 | 15,938,000,000.00 | 30,855,000,000.00 | 45,967.00 | 59,080,000,000.00 | 14,917,000,000.00 | 15,112.00 | 17,919,000,000.00 | 34,714,000,000.00 | 52,746.00 | 69,062,000,000.00 | 16,795,000,000.00 | 18,032.00 | 24,737,000,000.00 | 48,991,000,000.00 | 24,254,000,000.00 |
| Income Tax Expense Continuing Operations | 9,602,000,000.00 | 3,124,000,000.00 | 5,915,000,000.00 | 10,992,000,000.00 | 2,791,000,000.00 | 3,315,000,000.00 | 6,109,000,000.00 | 9,102.00 | 11,323,000,000.00 | 2,794,000,000.00 | 2,993.00 | 3,709,000,000.00 | 7,186,000,000.00 | 10,813.00 | 13,537,000,000.00 | 3,477,000,000.00 | 3,627.00 | 4,923,000,000.00 | 9,749,000,000.00 | 4,826,000,000.00 |
| Profit (loss) | 38,951,000,000.00 | 11,897,000,000.00 | 22,522,000,000.00 | 42,138,000,000.00 | 10,625,000,000.00 | 12,623,000,000.00 | 24,746,000,000.00 | 36,865.00 | 47,757,000,000.00 | 12,123,000,000.00 | 12,119.00 | 14,210,000,000.00 | 27,528,000,000.00 | 41,933.00 | 55,525,000,000.00 | 13,318,000,000.00 | 14,405.00 | 19,814,000,000.00 | 39,242,000,000.00 | 19,428,000,000.00 |
| Line item in (dkk) | 01.01.2019 | 01.01.2020 | 01.04.2020 | 01.07.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) | N/A | 38,951,000,000.00 | 11,897,000,000.00 | 10,625,000,000.00 | 42,138,000,000.00 | 12,623,000,000.00 | 12,123,000,000.00 | 12,119.00 | 47,757,000,000.00 | 14,210,000,000.00 | 13,318,000,000.00 | 14,405.00 | 55,525,000,000.00 | 19,814,000,000.00 | 19,428,000,000.00 |
| Adjustments For Income Tax Expense | N/A | 9,602,000,000.00 | 3,124,000,000.00 | 5,915,000,000.00 | 10,992,000,000.00 | 3,315,000,000.00 | 6,109,000,000.00 | 9,102.00 | 11,323,000,000.00 | 3,709,000,000.00 | 7,186,000,000.00 | 10,813.00 | 13,537,000,000.00 | 4,923,000,000.00 | 9,749,000,000.00 |
| Other Adjustments For Noncash Items | N/A | 7,032,000,000.00 | 5,998,000,000.00 | 9,139,000,000.00 | 7,849,000,000.00 | 1,034,000,000.00 | 9,172,000,000.00 | 14,647.00 | 13,009,000,000.00 | 7,388,000,000.00 | 11,805,000,000.00 | 28,707.00 | 22,310,000,000.00 | 20,230,000,000.00 | 30,935,000,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 204,000,000.00 | 112,000,000.00 | 116,000,000.00 | 422,000,000.00 | 50,000,000.00 | 85,000,000.00 | 141.00 | 261,000,000.00 | 52,000,000.00 | 120,000,000.00 | 186.00 | 272,000,000.00 | 165,000,000.00 | 262,000,000.00 |
| Interest Received Classified As Operating Activities | N/A | 64,000,000.00 | 17,000,000.00 | 37,000,000.00 | 100,000,000.00 | 13,000,000.00 | 43,000,000.00 | 149.00 | 241,000,000.00 | 48,000,000.00 | 109,000,000.00 | 148.00 | 276,000,000.00 | 188,000,000.00 | 409,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 46,782,000,000.00 | 10,012,000,000.00 | 34,273,000,000.00 | 51,951,000,000.00 | 11,255,000,000.00 | 36,510,000,000.00 | 58,017.00 | 55,000,000,000.00 | 23,586,000,000.00 | 47,547,000,000.00 | 71,786.00 | 78,887,000,000.00 | 29,814,000,000.00 | 58,391,000,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | -3,000,000.00 | N/A | N/A | 0.00 | N/A | N/A | N/A | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 0.00 | N/A | N/A | 0.00 | N/A | N/A | N/A | 18,283,000,000.00 | N/A | N/A | N/A | 7,075,000,000.00 | N/A | N/A |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 4,000,000.00 | N/A | N/A | 7,000,000.00 | N/A | N/A | N/A | 0.00 | N/A | N/A | N/A | 0.00 | N/A | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 8,932,000,000.00 | 1,667,000,000.00 | 2,906,000,000.00 | 5,825,000,000.00 | 1,402,000,000.00 | 3,111,000,000.00 | 4,286.00 | 6,335,000,000.00 | 1,520,000,000.00 | 3,955,000,000.00 | 7,185.00 | 12,146,000,000.00 | 4,693,000,000.00 | 10,571,000,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 2,299,000,000.00 | 56,000,000.00 | 184,000,000.00 | 16,256,000,000.00 | 97,000,000.00 | 272,000,000.00 | 785.00 | 1,050,000,000.00 | 260,000,000.00 | 400,000,000.00 | 1,395.00 | 2,607,000,000.00 | 108,000,000.00 | 1,265,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -11,509,000,000.00 | -2,106,000,000.00 | -3,473,000,000.00 | -22,436,000,000.00 | -3,481,000,000.00 | -6,367,000,000.00 | -11,002.00 | -31,605,000,000.00 | -1,907,000,000.00 | -6,107,000,000.00 | -11,068.00 | -24,918,000,000.00 | -6,647,000,000.00 | -15,932,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 15,334,000,000.00 | 2,690,000,000.00 | 8,211,000,000.00 | 16,855,000,000.00 | 2,960,000,000.00 | 8,400,000,000.00 | 11,935.00 | 19,447,000,000.00 | 4,477,000,000.00 | 11,927,000,000.00 | 16,547.00 | 24,086,000,000.00 | 5,199,000,000.00 | 14,022,000,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 81,000,000.00 | N/A | N/A | 5,682,000,000.00 | 0.00 | 0.00 | 82.00 | 22,160,000,000.00 | 30,000,000.00 | 30,000,000.00 | 0.00 | 11,215,000,000.00 | 0.00 | 0.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 822,000,000.00 | 420,000,000.00 | 428,000,000.00 | 950,000,000.00 | 349,000,000.00 | 6,072,000,000.00 | 6,329.00 | 6,689,000,000.00 | 12,855,000,000.00 | 13,099,000,000.00 | 13,399.00 | 13,623,000,000.00 | 478,000,000.00 | 851,000,000.00 |
| Dividends Paid Classified As Financing Activities | N/A | 19,409,000,000.00 | 12,551,000,000.00 | 12,551,000,000.00 | 20,121,000,000.00 | 13,495,000,000.00 | 13,496,000,000.00 | 21,517.00 | 21,517,000,000.00 | 15,690,000,000.00 | 15,690,000,000.00 | 25,303.00 | 25,303,000,000.00 | 18,337,000,000.00 | 18,337,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -35,484,000,000.00 | -13,509,000,000.00 | -21,190,000,000.00 | -32,244,000,000.00 | -14,475,000,000.00 | -18,311,000,000.00 | -30,042.00 | -25,493,000,000.00 | -19,135,000,000.00 | -29,566,000,000.00 | -44,129.00 | -51,797,000,000.00 | -20,621,000,000.00 | -33,210,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -211,000,000.00 | -5,603,000,000.00 | 9,610,000,000.00 | -2,729,000,000.00 | -6,701,000,000.00 | 11,832,000,000.00 | 16,973.00 | -2,098,000,000.00 | 2,544,000,000.00 | 11,874,000,000.00 | 16,589.00 | 2,172,000,000.00 | 2,546,000,000.00 | 9,249,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -7,000,000.00 | -95,000,000.00 | -170,000,000.00 | -456,000,000.00 | 154,000,000.00 | 169,000,000.00 | 291.00 | 591,000,000.00 | -55,000,000.00 | 163,000,000.00 | 606.00 | -238,000,000.00 | -263,000,000.00 | -328,000,000.00 |
| Cash and cash equivalents | 15,629,000,000.00 | 15,411,000,000.00 | 9,713,000,000.00 | 24,851,000,000.00 | 12,226,000,000.00 | 5,679,000,000.00 | 24,227,000,000.00 | 29,490.00 | 10,719,000,000.00 | 13,208,000,000.00 | 22,756,000,000.00 | 27,914.00 | 12,653,000,000.00 | 14,936,000,000.00 | 21,574,000,000.00 |
Please note that some sums might not add up.
DK0060534915
LEI549300DAQ1CVT6CXN342
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryOMX Copenhagen 20
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.